Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP

Watchlist Manager
Tonix Pharmaceuticals Holding Corp Logo
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Watchlist
Price: 40.87 USD -3.52% Market Closed
Market Cap: 299.2m USD

Relative Value

The Relative Value of one TNXP stock under the Base Case scenario is hidden USD. Compared to the current market price of 40.87 USD, Tonix Pharmaceuticals Holding Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TNXP Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
36
Median 3Y
1.2
Median 5Y
0
Industry
7.5
Forward
22.7
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.8
Industry
23.6
Forward
-3.1
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0.9
Industry
20.2
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.6
Industry
22.9
vs History
14
vs Industry
38
Median 3Y
0.2
Median 5Y
0.4
Industry
2.8
vs History
0
vs Industry
32
Median 3Y
-0.2
Median 5Y
0
Industry
7.7
Forward
12
vs History
0
vs Industry
12
Median 3Y
-0.8
Median 5Y
0
Industry
9.6
vs History
vs Industry
28
Median 3Y
0
Median 5Y
-0
Industry
4.9
vs History
vs Industry
27
Median 3Y
0
Median 5Y
-0
Industry
4.9
Forward
-1.4
vs History
vs Industry
30
Median 3Y
0
Median 5Y
-0.1
Industry
5.4
vs History
vs Industry
26
Median 3Y
0
Median 5Y
-0
Industry
4
vs History
22
vs Industry
44
Median 3Y
-0
Median 5Y
0
Industry
5.1

Multiples Across Competitors

TNXP Competitors Multiples
Tonix Pharmaceuticals Holding Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
281.1m USD 28 -2.1 -2.1 -2.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 932 910.7 -161 278.1 -195 843 -193 608.2
US
Abbvie Inc
NYSE:ABBV
339.9B USD 5.9 81.8 15.5 23
US
Amgen Inc
NASDAQ:AMGN
158.8B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
136.5B USD 4.8 22.9 10 13.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.5B USD 10.9 -121.8 25.9 27.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 076.1 -529.8 -576.9 -561.5
AU
CSL Ltd
ASX:CSL
116.7B AUD 5 27.9 17.2 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.4B USD 4.4 13.7 12.2 13.7
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.3 -66.1 -59.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41B USD 17.5 -152.2 -682.1 -341.8
P/E Multiple
Earnings Growth PEG
US
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Average P/E: 34.6
Negative Multiple: -2.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 278.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.9
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -121.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.8 N/A N/A
AU
CSL Ltd
ASX:CSL
27.9
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
7%
2
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -152.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Average EV/EBITDA: 15.9
Negative Multiple: -2.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 843 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.9 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -682.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Average EV/EBIT: 20.5
Negative Multiple: -2.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 608.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.7
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.2
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.5
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -341.8 N/A N/A